Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moskowitz

Showing results (281-290 of 298) with videos related to

Pageof 30
Sort By:
JAMA|March 27, 2019
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical TrialTerrence M Yau, Francis D Pagani, Donna M Mancini, et al.
JAMA Cardiology|June 8, 2022
External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical TrialDaniel J Goldstein, John D Puskas, John H Alexander, et al.
Circulation. Cardiovascular Quality and Outcomes|February 21, 2019
Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials NetworkBart S. Ferket, Gorav Ailawadi, Annetine C. Gelijns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2019
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II StudyMichael S Khodadoust, Alain H Rook, Pierluigi Porcu, et al.
The New England Journal of Medicine|April 9, 2015
Surgical ablation of atrial fibrillation during mitral-valve surgeryA Marc Gillinov, Annetine C Gelijns, Michael K Parides, et al.
American Heart Journal|December 22, 2021
Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary graftsEmilia Bagiella, John D Puskas, Alan J Moskowitz, et al.
Blood Advances|April 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapyWilliam T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, et al.
JAMA|August 9, 2017
Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical TrialMichael J Mack, Michael A Acker, Annetine C Gelijns, et al.
The New England Journal of Medicine|November 12, 2021
Concomitant Tricuspid Repair in Patients with Degenerative Mitral RegurgitationJames S Gammie, Michael W A Chu, Volkmar Falk, et al.
The Lancet. Oncology|August 14, 2018
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trialYoun H Kim, Martine Bagot, Lauren Pinter-Brown, et al.
Pageof 30

Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
JAMA|March 27, 2019
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical TrialTerrence M Yau, Francis D Pagani, Donna M Mancini, et al.
JAMA Cardiology|June 8, 2022
External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical TrialDaniel J Goldstein, John D Puskas, John H Alexander, et al.
Circulation. Cardiovascular Quality and Outcomes|February 21, 2019
Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials NetworkBart S. Ferket, Gorav Ailawadi, Annetine C. Gelijns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2019
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II StudyMichael S Khodadoust, Alain H Rook, Pierluigi Porcu, et al.
The New England Journal of Medicine|April 9, 2015
Surgical ablation of atrial fibrillation during mitral-valve surgeryA Marc Gillinov, Annetine C Gelijns, Michael K Parides, et al.
American Heart Journal|December 22, 2021
Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary graftsEmilia Bagiella, John D Puskas, Alan J Moskowitz, et al.
Blood Advances|April 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapyWilliam T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, et al.
JAMA|August 9, 2017
Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical TrialMichael J Mack, Michael A Acker, Annetine C Gelijns, et al.
The New England Journal of Medicine|November 12, 2021
Concomitant Tricuspid Repair in Patients with Degenerative Mitral RegurgitationJames S Gammie, Michael W A Chu, Volkmar Falk, et al.
The Lancet. Oncology|August 14, 2018
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trialYoun H Kim, Martine Bagot, Lauren Pinter-Brown, et al.
Pageof 30